Porcine Epidemic Diarrhea Vaccines Global Market Report 2026
상품코드:1957674
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
돼지 유행성 설사 백신 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 18억 달러에서 2026년에는 19억 4,000만 달러에 이르고, CAGR 7.6%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 돼지 유행성 설사병의 반복적인 발생, 신생 자돈의 높은 폐사율, 양돈 산업의 경제적 손실, 비백신 대책의 제한적인 효과, 수의사 주도의 질병 예방에 대한 의존도 증가 등이 그 원인으로 추정됩니다.
돼지 유행성 설사 백신 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 25억 달러에 이르고, CAGR은 6.7%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 집약적 양돈 방법의 확대, 돼지고기 제품에 대한 세계 수요 증가, 집단 면역의 이점에 대한 인식 개선, 조직화된 양돈장 확대, 정부의 동물 위생 지원 정책 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 돼지 건강 관리에서 백신 접종 확대, 전염병 발생 지역에서의 생백신 선호도 증가, 자돈의 조기 면역에 대한 관심 증가, 상업용 양돈장의 백신 접종 프로그램 확대, 바이오 보안 및 질병 관리 프로토콜에 대한 강조 강화 등이 있습니다.
향후 몇 년 동안 양돈업의 성장이 돼지 유행성 설사병 백신 시장의 성장을 견인할 것으로 예측됩니다. 양돈업이란 식육 생산을 목적으로 한 가축 돼지의 사육, 번식, 육성, 출생부터 출하체중까지의 관리, 그리고 돼지고기 제품의 생산 및 판매를 말합니다. 양돈업 증가는 돼지고기에 대한 세계 수요 증가, 번식 및 사육 방법의 개선, 양돈 시스템의 기술적 진보, 상업용 돼지고기 시장의 성장에 의해 촉진되고 있습니다. 돼지유행성설사병(PED) 백신은 양돈에 있어 필수적이며, 질병 발생을 예방하고 통제하는 데 기여합니다. 일반적으로 어미돼지의 임신 기간 동안 투여하여 신생 자돈에 대한 수동 면역을 제공합니다. 예를 들어, 2024년 4월 미국 정부기관인 미국 농무부는 미국의 돼지고기 생산량이 1,270만 톤에 달할 것으로 예측했습니다. 이는 돼지 생산량 증가를 의미하며, 양돈 산업의 지속적인 성장을 뒷받침하고 있습니다. 그 결과, 양돈의 확대는 돼지 유행성 설사병 백신 시장 확대에 기여하고 있습니다.
돼지유행성설사병(PED) 백신 시장에서 활동하는 주요 기업들은 면역력을 높이고 새로운 PEDV 균주에 대한 광범위한 보호를 제공하는 차세대 불활성화 백신 및 재조합 백신과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 차세대 불활성화 백신 및 재조합 백신은 불활성화 바이러스 또는 유전자 조작된 바이러스 단백질을 이용하여 강력한 표적 면역을 유도하는 동시에 안전성과 진화하는 병원체 균주에 대한 방어력을 향상시키는 첨단 백신입니다. 예를 들어, 2024년 8월 미국 동물용의약품 기업 조에티스(Zoetis Inc.)는 돼지유행성설사바이러스(PEDV) 백신 연구에 대한 보조금을 받고 미국 농무부(USDA)로부터 돼지 PEDV 백신에 대한 조건부 승인을 받았습니다. 이러한 노력은 지속적인 연구 지원, 백신 효능 향상, 새로운 PEDV 균주에 대한 방어 범위 확대를 통해 첨단 양돈 건강 솔루션 개발에서 조에티스의 입지를 강화할 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Porcine epidemic diarrhea vaccines are biological preparations designed to induce immunity against the porcine epidemic diarrhea virus, which leads to severe gastrointestinal illness in pigs. These vaccines play a crucial role in preventing and managing porcine epidemic diarrhea, supporting the health and productivity of pig herds and the economic stability of the swine industry.
The primary products of porcine epidemic diarrhea vaccines include live vaccines and inactivated vaccines. Live vaccines are biological formulations that contain attenuated or weakened versions of the porcine epidemic diarrhea virus (PEDV). Their applications encompass piglets and adult pigs and are utilized by various end-users, including veterinary clinics and hog production farms.
Tariffs have impacted the porcine epidemic diarrhea vaccines market by increasing the cost of imported vaccine raw materials, biological components, and cold-chain logistics equipment. These effects are most visible in live and inactivated vaccines supplied across major swine-producing regions such as Asia-Pacific and North America. Higher input costs have influenced vaccine pricing for hog production farms and veterinary hospitals. However, tariffs have also encouraged local vaccine manufacturing and strengthened regional self-sufficiency in animal health solutions.
The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine epidemic diarrhea vaccines market statistics, including porcine epidemic diarrhea vaccines industry global market size, regional shares, competitors with a porcine epidemic diarrhea vaccines market share, detailed porcine epidemic diarrhea vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. This porcine epidemic diarrhea vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.8 billion in 2025 to $1.94 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to recurring outbreaks of porcine epidemic diarrhea, high mortality rates in neonatal piglets, economic losses in the swine industry, limited effectiveness of non-vaccine disease control measures, increased reliance on veterinary-led disease prevention.
The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growth of intensive pig farming practices, rising global demand for pork products, increasing awareness of herd immunity benefits, expansion of organized hog production farms, supportive government animal health initiatives. Major trends in the forecast period include increasing adoption of preventive vaccination in swine health management, growing preference for live vaccines in endemic regions, rising focus on early immunization of piglets, expansion of vaccination programs in commercial hog farms, greater emphasis on biosecurity and disease control protocols.
The growth of pig farming is expected to drive the expansion of the porcine epidemic diarrhea vaccine market in the coming years. Pig farming entails raising domestic pigs for meat production, breeding, rearing, managing animals from birth to market weight, and producing and marketing pork products. The increase in pig farming is fueled by rising global demand for pork, improvements in breeding and herd management practices, technological advancements in swine production systems, and the growth of commercial pork markets. Porcine epidemic diarrhea (PED) vaccines are essential in pig farming, helping prevent and control disease outbreaks, with administration typically occurring during the sow's gestation period to provide passive immunity to newborn piglets. For example, in April 2024, the U.S. Department of Agriculture, a US-based government agency, projected U.S. pork production to reach 12.7 million metric tons, indicating increased swine output and supporting the ongoing growth of the pig farming industry. Consequently, the rise in pig farming is contributing to the expansion of the porcine epidemic diarrhea vaccine market.
Major companies operating in the Porcine Epidemic Diarrhea (PED) vaccines market are concentrating on creating innovative solutions such as next-generation inactivated and recombinant vaccines to boost immunity and offer broader protection against emerging PEDV strains. Next-generation inactivated and recombinant vaccines are advanced vaccines that utilize either killed viruses or engineered viral proteins to elicit strong, targeted immunity while enhancing safety and defense against evolving disease strains. For example, in August 2024, Zoetis Inc., a US-based animal health company, received a grant for Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and was also granted a conditional license by the U.S. Department of Agriculture (USDA) for a vaccine to combat PEDV in pigs. These initiatives reinforce Zoetis's position in developing advanced swine health solutions by supporting continued research, improving vaccine efficacy, and expanding protection against emerging PEDV strains.
In November 2024, Phibro Animal Health Corporation, a US-based health company, completed the acquisition of Zoetis Inc. for an undisclosed sum. The acquisition is intended to expand Phibro's product range in medicated feed additives and water-soluble products for cattle, swine, and poultry, enhancing its capacity to support animal health and nutrition globally. It also aims to boost Phibro's profitability, grow its revenue base, and provide capital for future investments in the animal health sector. Zoetis Inc. is a pharmaceutical manufacturing company that focuses on producing porcine epidemic diarrhea vaccines.
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saude Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the porcine epidemic diarrhea vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Porcine Epidemic Diarrhea Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses porcine epidemic diarrhea vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for porcine epidemic diarrhea vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The porcine epidemic diarrhea vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Live Vaccines; Killed Vaccines
2) By Application: Piglets; Adults Pigs
3) By End-User: Veterinary Hospitals; Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines; Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines; Inactivated Oral Vaccines
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Preventive Vaccination In Swine Health Management
4.2.2 Growing Preference For Live Vaccines In Endemic Regions
4.2.3 Rising Focus On Early Immunization Of Piglets
4.2.4 Expansion Of Vaccination Programs In Commercial Hog Farms
4.2.5 Greater Emphasis On Biosecurity And Disease Control Protocols
5. Porcine Epidemic Diarrhea Vaccines Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Hog Production Farms
5.3 Commercial Swine Farms
5.4 Animal Health Clinics
5.5 Agricultural Research Institutes
6. Porcine Epidemic Diarrhea Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Porcine Epidemic Diarrhea Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Porcine Epidemic Diarrhea Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Porcine Epidemic Diarrhea Vaccines Market Size, Comparisons And Growth Rate Analysis
7.3. Global Porcine Epidemic Diarrhea Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Porcine Epidemic Diarrhea Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Porcine Epidemic Diarrhea Vaccines Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Live Vaccines, Killed Vaccines
9.2. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Piglets, Adults Pigs
9.3. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Hospitals, Hog Production Farms
9.4. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral Live Vaccines, Injectable Live Vaccines
9.5. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Porcine Epidemic Diarrhea Vaccines Market
12.1. China Porcine Epidemic Diarrhea Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Porcine Epidemic Diarrhea Vaccines Market
13.1. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Porcine Epidemic Diarrhea Vaccines Market
14.1. Japan Porcine Epidemic Diarrhea Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Porcine Epidemic Diarrhea Vaccines Market
15.1. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Porcine Epidemic Diarrhea Vaccines Market
16.1. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Porcine Epidemic Diarrhea Vaccines Market
17.1. South Korea Porcine Epidemic Diarrhea Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Porcine Epidemic Diarrhea Vaccines Market
19.1. South East Asia Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Porcine Epidemic Diarrhea Vaccines Market
20.1. Western Europe Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Porcine Epidemic Diarrhea Vaccines Market
21.1. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Porcine Epidemic Diarrhea Vaccines Market
23.1. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market
26.1. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Porcine Epidemic Diarrhea Vaccines Market
27.1. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Porcine Epidemic Diarrhea Vaccines Market
28.1. North America Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Porcine Epidemic Diarrhea Vaccines Market
29.1. USA Porcine Epidemic Diarrhea Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Porcine Epidemic Diarrhea Vaccines Market
31.1. South America Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Porcine Epidemic Diarrhea Vaccines Market
32.1. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Porcine Epidemic Diarrhea Vaccines Market
33.1. Middle East Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Porcine Epidemic Diarrhea Vaccines Market
34.1. Africa Porcine Epidemic Diarrhea Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Porcine Epidemic Diarrhea Vaccines Market Regulatory and Investment Landscape
36. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape And Company Profiles
